Dr. Danish Nagda, a shareholder in the developer, told Fortune it was "incredibly exciting ... maybe half a decade away from ...
In a large-scale clinical trial, people taking daraxonrasib lived twice as long as those given standard chemotherapy.
On Wednesday, the U.S. Food and Drug Administration approved RASONQUE, a once-daily pill for adults with metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results